Tech Company Financing Transactions
Nectar Life Sciences Funding Round
Nectar Life Sciences closed a $8 million Seed financing round on 3/17/2022. Investors included Juxtapose and Obvious Ventures.
Transaction Overview
Company Name
Announced On
3/17/2022
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Proceeds Purpose
To build the nation's most personalized, accessible, and comprehensive allergy care platform.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Undisclosed, Undisclosed
Undisclosed
Undisclosed, Undisclosed
Undisclosed
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Description were not disclosed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kenneth Chahine
Browse more venture capital transactions:
Prev: 3/17/2022: Third Time Entertainment venture capital transaction
Next: 3/17/2022: Sesame HR venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs